Predictive Assay for Decision Making in Adjuvant Therapy
Public ClinicalTrials.gov record NCT05032352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Predictive Assay for Decision Making in Adjuvant Therapy (PADMA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective Registrational Trial to Define Real World Outcomes of Patients with Completely Resected Stage I or IIA (tumor \< or = 5cm, node negative) Non-squamous Non-Small Lung Cancer (NSCLC) Identified as High, Intermediate, or Low Risk by a 14-Gene Prognostic Assay DetermaRx being Considered for Adjuvant Platinum-based chemotherapy or other adjuvant therapy versus Observation
Study identification
- NCT ID
- NCT05032352
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2022 (Actual)
- Primary completion
- Oct 28, 2022 (Actual)
- Completion
- Oct 28, 2022 (Actual)
- Last update posted
- Nov 14, 2022
2022
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| George Washington Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| Jupiter Medical Center | Jupiter | Florida | 33458 | — |
| Piedmont Cancer Center | Atlanta | Georgia | 30309 | — |
| Northshore University Healthsystem | Evanston | Illinois | 60201 | — |
| The University of Kansas Hospital | Kansas City | Kansas | 66160 | — |
| Our Lady of the Lake Regional Medical Center | Baton Rouge | Louisiana | 70808 | — |
| Penn Presbyterian Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Texas Oncology-San Antonio Medical Center | San Antonio | Texas | 78240 | — |
| Methodist Healthcare | San Antonio | Texas | 78249 | — |
| Texas Oncology-Wichita Falls Cancer Center | Wichita Falls | Texas | 76310 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Mary Washington Hospital | Fredericksburg | Virginia | 22401 | — |
| Providence Regional Medical Center Everett | Everett | Washington | 98201 | — |
| Peace Health | Vancouver | Washington | 98683 | — |
| West Virginia University Medicine | Morgantown | West Virginia | 26506 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05032352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 14, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05032352 live on ClinicalTrials.gov.